Nevertheless, our findings demonstrate that Pontin is a vital cell cycle regulator at least by amplifying E2F1 transcription response in glioma, shedding light on the possibility of targeting Pontin for anti-glioma therapy. This evidence concerns the gene E2F1 and glioma.